Citation Impact
Citing Papers
HIV-1/ Mycobacterium tuberculosis Coinfection Immunology: How Does HIV-1 Exacerbate Tuberculosis?
2011
Species Interactions in a Parasite Community Drive Infection Risk in a Wildlife Population
2010 StandoutScience
Preferential infection and depletion of Mycobacterium tuberculosis –specific CD4 T cells after HIV-1 infection
2010
CD4+ Count–Guided Interruption of Antiretroviral Treatment
2006 Standout
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
2004 StandoutScience
Silica, silicosis and tuberculosis.
2007
Mycobacterium tuberculosis Infects Dendritic Cells with High Frequency and Impairs Their Function In Vivo
2007
The production of consumption: addressing the impact of mineral mining on tuberculosis in southern Africa
2009
Serial measurement of M. tuberculosis in blood from critically-ill patients with HIV-associated tuberculosis
2022 StandoutNobel
Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study
2008 Standout
Risk of Progression to Active Tuberculosis Following Reinfection With Mycobacterium tuberculosis
2012
The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling
2016 Standout
Syndemics and the biosocial conception of health
2017 Standout
Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD
2009
Matrix Metalloproteinases in Tuberculosis-Immune Reconstitution Inflammatory Syndrome and Impaired Lung Function Among Advanced HIV/TB Co-infected Patients Initiating Antiretroviral Therapy
2015 StandoutNobel
Pathogenesis and Risk Factors for Nontuberculous Mycobacterial Lung Disease
2014
Treatment of Active Tuberculosis in HIV‐Coinfected Patients: A Systematic Review and Meta‐Analysis
2010
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
2009 Standout
Clinical management of tuberculosis and HIV-1 co-infection
2010
Early Immunologic Failure is Associated With Early Mortality Among Advanced HIV–Infected Adults Initiating Antiretroviral Therapy With Active Tuberculosis
2013 StandoutNobel
Tuberculosis and HIV interaction in sub‐Saharan Africa: impact on patients and programmes; implications for policies
2005
Twelve-monthly versus six-monthly radiological screening for active case-finding of tuberculosis: a randomised controlled trial
2010
Prevalence of Tuberculosis, HIV and Respiratory Symptoms in Two Zambian Communities: Implications for Tuberculosis Control in the Era of HIV
2009
Outcome of HIV‐Associated Tuberculosis in the Era of Highly Active Antiretroviral Therapy
2004
Crohn's disease
2012 Standout
HIV-1 Infection Impairs the Bronchoalveolar T-Cell Response to Mycobacteria
2009
Human immunodeficiencies that predispose to intracellular bacterial infections
2005
The immunological life cycle of tuberculosis
2012
Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study
2015 StandoutNobel
Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis
2011
Tuberculosis Infection Control in Resource‐Limited Settings in the Era of Expanding HIV Care and Treatment
2007
Tuberculosis and silica exposure in South African gold miners
2006
Incidence of tuberculosis and HIV and progression of silicosis and lung function impairment among former basotho gold miners
2009
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
2008 Standout
HIV Infection and Multidrug‐Resistant Tuberculosis—The Perfect Storm
2007
Relapse and Acquired Rifampin Resistance in HIV-Infected Patients with Tuberculosis Treated with Rifampin- or Rifabutin-Based Regimens in New York City, 1997-2000
2005
Causes of Death on Antiretroviral Therapy: A Post-Mortem Study from South Africa
2012
Antibiotic resistance and its cost: is it possible to reverse resistance?
2010 Standout
Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome
2015 StandoutNobel
Tuberculosis and lung damage: from epidemiology to pathophysiology
2018 StandoutNobel
Impact of HIV Infection on the Epidemiology of Tuberculosis in a Peri-Urban Community in South Africa: The Need for Age-Specific Interventions
2006
Morbidity and Mortality in South African Gold Miners: Impact of Untreated Disease Due to Human Immunodeficiency Virus
2002
Epidemiology of HIV-associated tuberculosis
2009
Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis
2012
Antituberculosis drug resistance and anonymous HIV surveillance in tuberculosis patients in Botswana, 2002
2005
Tuberculosis control and elimination 2010–50: cure, care, and social development
2010 Standout
The Mycobacterium tuberculosis Virulence Factor Trehalose Dimycolate Imparts Desiccation Resistance to Model Mycobacterial Membranes
2008 StandoutNobel
Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa
2006 Standout
Sensitivity optimisation of tuberculosis bioaerosol sampling
2020 StandoutNobel
Illumination of growth, division and secretion by metabolic labeling of the bacterial cell surface
2015 StandoutNobel
M. tuberculosis persistence, latency, and drug tolerance
2003
Burden of New and Recurrent Tuberculosis in a Major South African City Stratified by Age and HIV-Status
2011
Health Risks of Gold Miners: A Synoptic Review
2003
Tuberculosis
2007
Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS
2009 Standout
Update on pulmonary disease due to non-tuberculous mycobacteria
2016
HIV infection and silicosis: the impact of two potent risk factors on the incidence of mycobacterial disease in South African miners
2000
Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment
2006
Effects of chloroquine on viral infections: an old drug against today's diseases
2003 Standout
Regulation of type I interferon responses
2013 Standout
CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial
2006
Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review
2014 Standout
Cyclopropane Modification of Trehalose Dimycolate Drives Granuloma Angiogenesis and Mycobacterial Growth through Vegf Signaling
2018 StandoutNobel
Survival and mortality of people infected with HIV in low and middle income countries: results from the extended ALPHA network
2007
Tuberculosis
2003
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
2010 Standout
Incorporating a Rapid-Impact Package for Neglected Tropical Diseases with Programs for HIV/AIDS, Tuberculosis, and Malaria
2006 Standout
Opportunities and Challenges for HIV Care in Overlapping HIV and TB Epidemics
2008
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
2017 StandoutNobel
HIV-1/AIDS and the control of other infectious diseases in Africa
2002
Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis
2014
Drivers of tuberculosis epidemics: The role of risk factors and social determinants
2009 Standout
Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma
2010
Sulfate Metabolism in Mycobacteria
2006 StandoutNobel
Impact of DOTS expansion on tuberculosis related outcomes and costs in Haiti
2006
The Growing Burden of Tuberculosis
2003 Standout
Silicosis
2012 Standout
Multidrug-resistant tuberculosis at an HIV testing center in Haiti
2006
The Sound of One Hand Clapping
2005
The ongoing challenge of latent tuberculosis
2014
The clinical spectrum of pulmonary aspergillosis
2014
Rv2131c fromMycobacterium tuberculosisIs a CysQ 3′-Phosphoadenosine-5′-phosphatase
2008 StandoutNobel
Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment
2008
Garlic: a review of potential therapeutic effects.
2014 Standout
Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision
2017 Standout
Three Decades of Silicosis: Disease Trends at Autopsy in South African Gold Miners
2009
Control of Chronic Mycobacterium tuberculosis Infection by CD4 KLRG1− IL-2–Secreting Central Memory Cells
2013
Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study
2019 StandoutNobel
The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis
2011
Latent Tuberculosis Infection: Myths, Models, and Molecular Mechanisms
2014
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
HIV Status and Labor Market Participation in South Africa
2011
Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa
2001
Tuberculose e silicose: epidemiologia, diagnóstico e quimioprofilaxia
2008
The Immune Response in Tuberculosis
2013 Standout
Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV–tuberculosis coinfected populations
2006
Point-of-Care Diagnostics for Global Health
2008 Standout
Infection Source and Epidemiology of Nontuberculous Mycobacterial Lung Disease
2018 Standout
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB
2017 StandoutNobel
The potential role of garlic (Allium sativum) against the multi-drug resistant tuberculosis pandemic: a review.
2011
Why has unemployment risen in the New South Africa?1
2008 StandoutNobel
Mycobacterium tuberculosisPromotes HIVtrans-Infection and Suppresses Major Histocompatibility Complex Class II Antigen Processing by Dendritic Cells
2010
Acute Modulation of Mycobacterial Cell Envelope Biogenesis by Front‐Line Tuberculosis Drugs
2018 StandoutNobel
Global Water Pollution and Human Health
2010 Standout
Initial Drug Resistance and Tuberculosis Treatment Outcomes: Systematic Review and Meta-analysis
2008
Hidden Killers: Human Fungal Infections
2012 Standout
Cell-Mediated Immune Responses in Tuberculosis
2009 Standout
Effects of Human Immunodeficiency Virus Infection on Recurrence of Tuberculosis after Rifampin-Based Treatment: An Analytical Review
2003
Factors associated with an increased case-fatality rate in HIV-infected and non-infected South African gold miners with pulmonary tuberculosis.
2000
HIV and Tuberculosis: a Deadly Human Syndemic
2011
Works of Stuart Shearer being referenced
HIV and pulmonary tuberculosis
2004
Risk factors for pulmonary disease due to culture‐positive M. tuberculosis or nontuberculous mycobacteria in South African gold miners
2000
Survival from HIV-1 seroconversion in Southern Africa: a retrospective cohort study in nearly 2000 gold-miners over 10 years of follow-up
2007
Effect of HIV on work-related injury rates in South African gold miners
2005
Effects of duration of HIV infection and secondary tuberculosis transmission on tuberculosis incidence in the South African gold mines
2008
HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers
2001
Tuberculosis treatment failure and drug resistance—same strain or reinfection?
2000
Cause of death and presence of respiratory disease at autopsy in an HIV-1 seroconversion cohort of southern African gold miners
2007
How Soon after Infection with HIV Does the Risk of Tuberculosis Start to Increase? A Retrospective Cohort Study in South African Gold Miners
2004
High Rates of Recurrence in HIV‐Infected and HIV‐Uninfected Patients with Tuberculosis
2010
Human Immunodeficiency Virus and the Outcome of Treatment for New and Recurrent Pulmonary Tuberculosis in African Patients
1999